v3.26.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common stock
Additional paid-in capital
Accumulated deficit
Beginning balance (in shares) at Dec. 31, 2024 479,332,885 479,332,885    
Beginning balance at Dec. 31, 2024 $ 611,146 $ 479 $ 938,604 $ (327,937)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net loss (61,054)     (61,054)
Stock-based compensation 7,768   7,768  
Issuance of replacement stock-based compensation 232   232  
Issuance of common shares (in shares)   74,311,252    
Issuance of common shares 89,864 $ 74 89,790  
Issuance of equity warrants $ 14,192   14,192  
Settlement of restricted share units (in shares) 2,347,500 2,347,500    
Settlement of restricted share units $ 0 $ 2 (2)  
Settlement of performance share units/share awards (in shares) 1,543,320 1,543,320    
Settlement of share awards $ 0 $ 2 (2)  
Exercise of stock options and warrants (in shares)   13,900    
Exercise of stock options and warrants $ 3   3  
Ending balance (in shares) at Jun. 30, 2025 557,548,857 557,548,857    
Ending balance at Jun. 30, 2025 $ 662,151 $ 557 1,050,585 (388,991)
Beginning balance (in shares) at Mar. 31, 2025   553,644,137    
Beginning balance at Mar. 31, 2025 661,434 $ 553 1,044,371 (383,490)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net loss (5,501)     (5,501)
Stock-based compensation 3,500   3,500  
Issuance of equity warrants 2,715   2,715  
Settlement of restricted share units (in shares)   2,347,500    
Settlement of restricted share units 0 $ 2 (2)  
Settlement of performance share units/share awards (in shares)   1,543,320    
Settlement of share awards 0 $ 2 (2)  
Exercise of stock options and warrants (in shares)   13,900    
Exercise of stock options and warrants $ 3   3  
Ending balance (in shares) at Jun. 30, 2025 557,548,857 557,548,857    
Ending balance at Jun. 30, 2025 $ 662,151 $ 557 1,050,585 (388,991)
Beginning balance (in shares) at Dec. 31, 2025 601,579,999 601,579,999    
Beginning balance at Dec. 31, 2025 $ 560,375 $ 602 1,172,254 (612,481)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net loss (210,348)     (210,348)
Stock-based compensation 13,512   13,512  
Purchase of capped calls, including transaction costs $ (41,840)   (41,840)  
Settlement of restricted share units (in shares) 1,814,533 1,814,533    
Settlement of restricted share units $ 0 $ 2 (2)  
Settlement of performance share units/share awards (in shares) 0 77,525    
Exercise of stock options and warrants (in shares)   13,264,050    
Exercise of stock options and warrants $ 7,017 $ 13 7,004  
Ending balance (in shares) at Jun. 30, 2026 616,736,107 616,736,107    
Ending balance at Jun. 30, 2026 $ 328,716 $ 617 1,150,928 (822,829)
Beginning balance (in shares) at Mar. 31, 2026   602,851,137    
Beginning balance at Mar. 31, 2026 419,135 $ 603 1,176,366 (757,834)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net loss (64,995)     (64,995)
Stock-based compensation 9,848   9,848  
Purchase of capped calls, including transaction costs (41,840)   (41,840)  
Settlement of restricted share units (in shares)   882,258    
Settlement of restricted share units 0 $ 1 (1)  
Settlement of performance share units/share awards (in shares)   77,525    
Exercise of stock options and warrants (in shares)   12,925,187    
Exercise of stock options and warrants $ 6,568 $ 13 6,555  
Ending balance (in shares) at Jun. 30, 2026 616,736,107 616,736,107    
Ending balance at Jun. 30, 2026 $ 328,716 $ 617 $ 1,150,928 $ (822,829)